Skip to content

A Clinical Study on the Feasibility and Safety of Abdominal Endoscopic Single-port Surgery System to Assist Gynecological Day Surgery

A Clinical Study on the Feasibility and Safety of Abdominal Endoscopic Single-port Surgery System to Assist Gynecological Day Surgery

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06828419
Enrollment
63
Registered
2025-02-14
Start date
2025-04-10
Completion date
2026-12-31
Last updated
2025-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenopathy, Adnexal Cyst, Adnexal Diseases, Adnexal Mass, Ovarian Cysts, Ovarian Diseases, Uterine Fibroids

Keywords

robotic-assisted laparoscopic single-site surgery (R-LESS), single-port robot system (SPRS), day surgery

Brief summary

In this study, a prospective study is used to select patients who will undergo intra-abdominal endoscopic single-port surgery system for benign gynecological diseases from February 2025 to December 2026 in the Second Affiliated Hospital of Wenzhou Medical University, including hysterectomy, myomectomy, ovarian cyst removal and adnexectomy. The study will perform statistical analysis to evaluate the feasibility and the main factors affecting the safety of intra-abdominal endoscopic single-port surgery system(SR-ENS-600) used in gynecological day surgery.

Interventions

DEVICEDomestic single-port laparoscopic surgery system

The minimum distance of the single-port surgical system from the port is 5-7cm to obtain the instrument bending space. The load capacity of surgical tools is increased from 2N to 5N, which greatly improves the structural reliability. At the same time, it can realize 6 degrees of freedom movement。

Sponsors

Second Affiliated Hospital of Wenzhou Medical University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Women aged 18 to 75 years old, with a body mass index (BMI) of no more than 32 kg/m2; 2. Conscious, no history of mental illness, accompanied by an adult during the perioperative period; 3. Educate the subjects, who are willing to undergo day surgery, understand and accept the surgical method and anesthesia method; 4. Subjects and families understand perioperative care and are willing and able to complete post-discharge care; 5. Elective surgery, no serious complications affecting the operation and prognosis, aCCI age adjusted comorbidity index 0 points; 6. According to the adhesion risk scoring system of European Anti-Adhesions in Gynaecology Expert Panel (ANGEL), the adhesion risk was divided into three levels: high, medium and low. Subjects with low risk (0 to 12 points) and abdominal wall scarring and pelvic cavity B-ultrasonography do not indicate obvious pelvic cavity adhesion wiil be included.

Exclusion criteria

1. Moderate and high-risk patients will be excluded based on ANGEL adhesion risk scoring system; 2. Subjects with hemorrhagic rupture of ectopic pregnancy and unstable vital signs; 3. Genital tract infection or in the acute phase of systemic infection; 4. Subjects on long-term anticoagulant therapy or with coagulation dysfunction; 5. Subjects have severe heart and lung disease, liver and kidney dysfunction, and cannot tolerate anesthesia; 6. A history of abdominal or diaphragmatic hernia, abnormal umbilical cord development, or umbilical surgery; 7. Not willing to undergo endoscopic surgery; 8. Participated in other drug and device clinical trials within 3 months before surgery.

Design outcomes

Primary

MeasureTime frameDescription
Day Surgery Success RatePatient recruitment ends and all patients complete surgery, up to 2 yearsDay surgery success rate means that no other operation is performed during the operation and the patient is discharged within 48 hours.

Secondary

MeasureTime frameDescription
Blood Loss EvaluationFrom the time of hemoglobin measurement before surgery to the time of hemoglobin measurement after surgery, up to 1 day after surgeryThe estimated intraoperative blood loss and the difference of hemoglobin before and after operation.
Surgeon Satisfaction EvaluationUp to 1 day after surgerySurgeon satisfaction questionnaire
Time of First Postoperative Anal ExhaustUp to 2 day after surgerytime recording
First Spontaneous Urination TimeUp to 2 day after surgeryTime recording
Pain Score4 hours after surgeryVisual Analogue Scale(VAS)
Hospital StaysFrom the date of admission to the Date of discharge, assessed up to 2 daysTime
Time of OperationFrom pre-surgery to the end of surgery,up to 12 hoursTime of operation includes total operation time, operator teleoperation time, robot system parking time and instrument docking time。
Abdominal Incision HealingWithin 1 day after surgeryObservation
Scar Satisfaction30 days after dischargeScar Cosmesis Assessment and Rating(SCAR)
Discharge AssessmentWithin 1 day after surgery, 4 hours after dischargePostanesthesia Discharge Score(PADS)
Postoperative Complication4 hours, 24 hours and 30 days after dischargeTelephone, Wechat official account and outpatient follow-up
Quality and Safety Evaluation of Day Surgery30 days after discharge13 indexes of quality and safety evaluation of day surgery
Safety EvaluationDay of surgery and within 1 day after surgery; 4 hours, 24 hours and 30 days after discharge6 indexes of safety evaluations
Postoperative Rehabilitation EvaluationWithin 1 day after surgery; 24 hours and 30 days after dischargeQuality of Life-15(QOL-15)

Countries

China

Contacts

Primary ContactXingyu Yang, Master
yangxy_822@163.com+86 173 9805 4822
Backup ContactPing Duan, Master
dppddpp@126.com+86 135 8743 0406

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026